camden national - CAC
CAC
Close Chg Chg %
49.07 1.24 2.53%
Pre-Market
50.31
+1.24 (2.53%)
Volume: 115.88K
Last Updated:
Apr 8, 2026, 4:00 PM EDT
Company Overview: camden national - CAC
CAC Key Data
| Open $50.47 | Day Range 49.80 - 50.58 |
| 52 Week Range 34.53 - 51.57 | Market Cap $851.51M |
| Shares Outstanding 16.93M | Public Float 16.54M |
| Beta 0.58 | Rev. Per Employee N/A |
| P/E Ratio 13.11 | EPS $3.85 |
| Yield 333.93% | Dividend $0.42 |
| EX-DIVIDEND DATE Apr 15, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 97.78K |
CAC Performance
No Data Available
CAC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 51.333 | |
| Number of Ratings | 4 | Current Quarters Estimate | 1.335 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | 5.413 | |
| Last Quarter’s Earnings | 1.25 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 4.39 | Next Fiscal Year Estimate | 5.88 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 4 | 4 | 4 |
| Mean Estimate | 1.33 | 1.38 | 5.41 | 5.88 |
| High Estimates | 1.35 | 1.41 | 5.45 | 6.17 |
| Low Estimate | 1.32 | 1.34 | 5.35 | 5.70 |
| Coefficient of Variance | 0.95 | 2.16 | 0.88 | 3.59 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 0 | 0 | 1 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 3 | 3 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Hold | Overweight |
SEC Filings for Camden National - CAC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Camden National - CAC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 18, 2026 | Barbara Raths EVP | 7,945 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $45.48 per share | 361,338.60 |
| Mar 12, 2026 | Brandon Y. Boey SVP | 2,989 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $45.83 per share | 136,985.87 |
| Mar 12, 2026 | David Ackley EVP | 12,211 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $45.83 per share | 559,630.13 |
| Dec 18, 2025 | Simon R. Griffiths CEO | 31,275 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $45.68 per share | 1,428,642.00 |
| Sep 24, 2025 | Raina L. Maxwell Director | 2,136 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $40.22 per share | 85,909.92 |
| Sep 24, 2025 | Lawrence J. Sterrs Director | 14,565 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $40.22 per share | 585,804.30 |
| Sep 24, 2025 | Rebecca K. Hatfield Director | 7,177 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $40.22 per share | 288,658.94 |
| Sep 24, 2025 | Carl John Soderberg Director | 100,419 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $40.22 per share | 4,038,852.18 |
| Sep 24, 2025 | Larry K. Haynes Director | 2,506 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $40.22 per share | 100,791.32 |
| Sep 24, 2025 | Marie J. McCarthy Director | 15,578 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $40.22 per share | 626,547.16 |
| Jun 4, 2025 | Robert D. Merrill Director | 10,505 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 4, 2025 | Craig N. Denekas Director | 14,626 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 4, 2025 | S. Catherine Longley Director | 13,052 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 4, 2025 | James H. Page Director | 9,977 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 4, 2025 | Robin A. Sawyer Director | 10,472 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Garrett McKnight EVP | 4,321 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $41.49 per share | 179,278.29 |
| May 20, 2025 | Michael R. Archer EVP | 17,556 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $41.49 per share | 728,398.44 |
| Apr 18, 2025 | Andrew Forbes EVP | 3,068 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $37.4 per share | 114,743.20 |